Gilead Sciences Continues to Lead Anti-viral Drugs Market, Says Fairfield Market Research
Gilead Sciences Continues to Lead Anti-viral Drugs Market, Says Fairfield Market Research iCrowd Newswire 20 May 2021, 00:27 GMT+10 Highly infectious diseases such as avian flu, swine flu, and most recently COVID-19, pose an existential threat to human health and safety worldwide. Communicable viral infections account for a substantial portion of healthcare costs. Humanity has managed to successfully eliminate only smallpox and rinderpest (a disease afflicting cattle) so far. World Health Organization (WHO) data states that parasitic diseases trail cardiovascular ailment in terms of mortality...
Source: texasguardian.com